Term ended Feb 3, 2026 · Medium confidence
20-year base term ended Feb 3, 2026
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 8,052,996), so the cap could be lower.
Feb 3, 2006
Feb 3, 2026
Sep 25, 2012
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees were paid, so no fee lapse ended it. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 3, 2006, when application 11/347,562, the earliest non-provisional in its chain, was filed (this one was filed Mar 29, 2012) | Feb 3, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,052,996, US 8,114,437, US 8,158,150) | resolves to Feb 3, 2026, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Feb 3, 2026 | Medium confidence |
This family
| US 8,114,437 | In force Aug 2027 | Aug 2027 |
| US 8,052,996 | In force no later than Feb 2029 | no later than Feb 2029 |
| US 8,299,025 | Term ended Feb 2026 | Feb 2026 |
| US 8,211,467 | Term ended Feb 2026 | Feb 2026 |
| US 8,940,316 | In force no later than Jan 2029 | no later than Jan 2029 |
| US 8,206,745 | Term ended Feb 2026 | Feb 2026 |
| US 8,158,150 | Term ended Feb 2026 | Feb 2026 |
| US 8,273,365 | this patent Feb 2026 | Feb 2026 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 14, 2012 Reel 29299, frame 678 | Intarcia Therapeutics, Inc. | U.S. Bank National Association, as Collateral Agent | Security Agreement |
| Mar 25, 2015 Reel 35255, frame 803 | Lautenbach, Scott D.; De La Serna, Pedro E.; Zamora, Pauline C.; Desjardin, Michael A. | Intarcia Therapeutics Inc. | Assignment of Assignor's Interest |
| Oct 23, 2015 Reel 36942, frame 544 | U.S. Bank National Association, as Collateral Agent | Intarcia Therapeutics, Inc. | Release of Security Interest |
| Oct 9, 2019 Reel 50673, frame 20 | Intarcia Therapeutics, Inc.; Intarcia Ireland Limited | Midcap Financial Trust, As Agent | Security Interest |
| Oct 23, 2019 Reel 50801, frame 267 | Intarcia Therapeutics, Inc. | Baupost Private Investments Bviv-3, L.L.C., as Collateral Agent | Security Interest |
| Jan 29, 2020 Reel 51739, frame 453 | Baupost Private Investments Bviv-3, L.L.C. as Collateral Agent | Intarcia Therapeutics, Inc. | Release of Security Interest |
| Apr 17, 2020 Reel 52433, frame 1 | Midcap Financial Trust, As Agent | Intarcia Therapeutics, Inc.; Intarcia Ireland Limited | Release of Security Interest |
| Apr 17, 2020 reel/frame not recorded | Midcap Financial Trust, As Agent | Intarcia Therapeutics, Inc. | Release of Security Interest |
| Apr 17, 2020 reel/frame not recorded | Midcap Financial Trust, As Agent | Intarcia Ireland Limited | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
A terminal disclaimer resolved from the filed document, referencing US 8,052,996, US 8,114,437, US 8,158,150, ends no earlier than this term, so it caps nothing.